Evidence map›Paper›PMID 38326762›Full record

SynthesisBMC infectious diseases2024

Diagnosis of human leptospirosis: systematic review and meta-analysis of the diagnostic accuracy of the Leptospira microscopic agglutination test, PCR targeting Lfb1, and IgM ELISA to Leptospira fainei serovar Hurstbridge.

Marta Valente, Justina Bramugy, Suzanne H Keddie, Heidi Hopkins, Quique Bassat, Oliver Baerenbold, John Bradley, Jane Falconer, Ruth H Keogh, Paul N Newton and 2 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Ecological Niche Modeling of PathogenicPathogens (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Diagnostic Performance of Two Commercial qPCR Kits forTropical medicine and infectious disease · 2026
    Article
  8. Review
  9. Retrospective Molecular Detection and Characterization of PathogenicTropical medicine and infectious disease · 2026
    Article
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marta Valente *ISGlobal, Hospital Clínic - Universitat de Barcelona, Calle Rosselló, 171, Entresol, Barcelona, 08036, Spain. anamarta.valente@gmail.com.
Justina Bramugy *Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Suzanne H Keddie *London School of Hygiene & Tropical Medicine, London, UK.
Heidi HopkinsLondon School of Hygiene & Tropical Medicine, London, UK.
Quique BassatISGlobal, Hospital Clínic - Universitat de Barcelona, Calle Rosselló, 171, Entresol, Barcelona, 08036, Spain.
Oliver BaerenboldLondon School of Hygiene & Tropical Medicine, London, UK.
John BradleyLondon School of Hygiene & Tropical Medicine, London, UK.
Jane FalconerLondon School of Hygiene & Tropical Medicine, London, UK.
Ruth H KeoghLondon School of Hygiene & Tropical Medicine, London, UK.
Paul N NewtonCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mathieu PicardeauBiology of Spirochetes Unit, French National Reference Centre for Leptospirosis, Institut Pasteur, Université Paris Cité, Paris, F-75015, France.
John A CrumpCentre for International Health, University of Otago, Dunedin, New Zealand.

Funding

Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
EDCTP Fellowship grant TMA2019SFP2836TFFIC NIH HHS R01 TW009237Medical Research Council London Intercollegiate Doctoral Training Partnership Studentship MR/N013638/1NIAID NIH HHS R01 AI121378Severo Ochoa Scholarship Reference PRE2019-088336US National Institutes of Health grants R01TW009237 and R01 AI121378
6 · The paper itself

Abstract

backgroundLeptospirosis is an underdiagnosed infectious disease with non-specific clinical presentation that requires laboratory confirmation for diagnosis. The serologic reference standard remains the microscopic agglutination test (MAT) on paired serum samples. However, reported estimates of MAT's sensitivity vary. We evaluated the accuracy of four index tests, MAT on paired samples as well as alternative standards for leptospirosis diagnosis: MAT on single acute-phase samples, polymerase chain reaction (PCR) with the target gene Lfb1, and ELISA IgM with Leptospira fainei serovar Hurstbridge as an antigen.

methodsWe performed a systematic review of studies reporting results of leptospirosis diagnostic tests. We searched eight electronic databases and selected studies that tested human blood samples and compared index tests with blood culture and/or PCR and/or MAT (comparator tests). For MAT selection criteria we defined a threshold for single acute-phase samples according to a national classification of leptospirosis endemicity. We used a Bayesian random-effect meta-analysis to estimate the sensitivity and specificity of MAT in single acute-phase and paired samples separately, and assessed risk of bias using the Quality Assessment of Studies of Diagnostic Accuracy Approach- 2 (QUADAS-2) tool.

resultsFor the MAT accuracy evaluation, 15 studies were included, 11 with single acute-phase serum, and 12 with paired sera. Two included studies used PCR targeting the Lfb1 gene, and one included study used IgM ELISA with Leptospira fainei serovar Hurstbridge as antigen. For MAT in single acute-phase samples, the pooled sensitivity and specificity were 14% (95% credible interval [CrI] 3-38%) and 86% (95% CrI 59-96%), respectively, and the predicted sensitivity and specificity were 14% (95% CrI 0-90%) and 86% (95% CrI 9-100%). Among paired MAT samples, the pooled sensitivity and specificity were 68% (95% CrI 32-92%) and 75% (95% CrI 45-93%) respectively, and the predicted sensitivity and specificity were 69% (95% CrI 2-100%) and 75% (2-100%).

conclusionsBased on our analysis, the accuracy of MAT in paired samples was not high, but it remains the reference standard until a more accurate diagnostic test is developed. Future studies that include larger numbers of participants with paired samples will improve the certainty of accuracy estimates.

Indexed as

LeptospiraLeptospirosisAgglutination TestsAntibodies, BacterialBayes TheoremEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin MPolymerase Chain ReactionSensitivity and SpecificitySerogroupAntibodies, BacterialImmunoglobulin MAgglutinations testsEnzyme-linked immunosorbent assayLeptospirosisMeta-analysisPolymerase chain reactionSensitivity and specificitySystematic review

Identifiers

PMID38326762
PMCPMC10848445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.